Sara Radcliffe, President and CEO of the California Life Sciences Association, discusses where Scott Gottlieb, M.D., is most likely to impact biopharma, and what the industry hopes he will accomplish as the FDA’s new commissioner.
Credit: Nenov Brothers - Fotolia
FDA’s New Commissioner Hits the Ground Running
Credit: Nenov Brothers - Fotolia